Details for New Drug Application (NDA): 018296
✉ Email this page to a colleague
The generic ingredient in TYMTRAN is ceruletide diethylamine. There is one drug master file entry for this compound. Additional details are available on the ceruletide diethylamine profile page.
Summary for 018296
Tradename: | TYMTRAN |
Applicant: | Pharmacia And Upjohn |
Ingredient: | ceruletide diethylamine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.02MG/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018296
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | TYMTRAN | ceruletide diethylamine | INJECTABLE;INJECTION | 018296-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription